Back to GUGGENHEIM CAPITAL LLC GUGGENHEIM CAPITAL LLC

LLYLLY

Showing 8 of 30 quarters

Position history for GUGGENHEIM CAPITAL LLCGUGGENHEIM CAPITAL LLC's holdings in Eli Lilly and Company

Yes. Guggenheim Capital holds 39,113 shares of LLY (Eli Lilly), worth $46.9M, as of its Q2 2026 13F filing. It increased the position by 3,762 shares (+10.6%) from Q1 2026. Guggenheim Capital has held LLY in every 13F on record since Q1 2019, 30 quarterly filings. LLY is 0.3% of Guggenheim Capital's reported 13F portfolio.

Current Value

$46.9M

Current Shares

39,113

Total Value Change

+$14.4M

Total Shares Change

+2,398

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
39,113
+10.6%
$46.9M0.3%$1,197.71
39
2026-Q1
Increased
35,351
+3.7%
$32.5M0.3%$916.88
36
2025-Q4
Increased
34,088
+2.7%
$36.6M0.3%$1,069.51
36
2025-Q3
Increased
33,188
+30.5%
$25.3M0.2%$758.22
43
2025-Q2
Increased
25,431
+5.9%
$19.8M0.2%$772.95
36
2025-Q1
Decreased
24,020
-25.8%
$19.8M0.2%$817.26
0
2024-Q4
Decreased
32,366
-11.8%
$25M0.2%$762.60
0
2024-Q3
Decreased
36,715
-21.1%
$32.5M0.2%$873.71
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used